Today: Today, UBS Asset Management Americas Inc. decides to keep it stake in Monsanto Co. (MON) to the level of $144,570,000

Today, UBS Asset Management Americas Inc. decides to keep it stake in Monsanto Co. (MON) to the level of $144,570,000

UBS Asset Management Americas Inc. reduced its position in shares of Monsanto Co. (NYSE:MON) by 8.5% during the third quarter, Holdings Channel reports. The institutional investor owned 1,414,564 shares of the company’s stock after selling 132,084 shares during the period. UBS Asset Management Americas Inc.’s holdings in Monsanto were worth $144,570,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in MON. Vanguard Group Inc. raised its position in shares of Monsanto by 1.3% in the second quarter. Vanguard Group Inc. now owns 30,430,570 shares of the company’s stock worth $3,146,826,000 after buying an additional 389,914 shares in the last quarter. FMR LLC raised its position in shares of Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Monsanto by 0.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 14,893,956 shares of the company’s stock worth $1,540,185,000 after buying an additional 38,316 shares in the last quarter. Capital International Investors raised its position in shares of Monsanto by 6.2% in the second quarter. Capital International Investors now owns 8,187,701 shares of the company’s stock worth $846,690,000 after buying an additional 476,848 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Monsanto by 2.8% in the third quarter. Bank of New York Mellon Corp now owns 6,208,049 shares of the company’s stock worth $634,462,000 after buying an additional 171,970 shares in the last quarter. Hedge funds and other institutional investors own 73.94% of the company’s stock.

Shares of Monsanto Co. (NYSE:MON) opened at 102.03 on Tuesday. The stock has a 50 day moving average of $100.97 and a 200 day moving average of $104.18. The firm has a market cap of $44.69 billion, a P/E ratio of 34.15 and a beta of 1.01. Monsanto Co. has a 52 week low of $83.73 and a 52 week high of $114.26.

Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business had revenue of $2.56 billion for the quarter, compared to analysts’ expectations of $2.38 billion. During the same quarter in the previous year, the business posted ($0.19) EPS. Monsanto’s revenue for the quarter was up 8.8% on a year-over-year basis. Equities analysts forecast that Monsanto Co. will post $4.73 earnings per share for the current year.

MON has been the subject of a number of recent analyst reports. S&P Equity Research reiterated a “positive” rating on shares of Monsanto in a research report on Thursday, September 15th. Piper Jaffray Cos. reissued an “overweight” rating and issued a $118.00 price target on shares of Monsanto in a report on Sunday, August 21st. downgraded shares of Monsanto from a “buy” rating to an “underperform” rating and set a $110.00 price target for the company. in a report on Thursday, September 15th. Zacks Investment Research downgraded shares of Monsanto from a “hold” rating to a “strong sell” rating in a report on Friday, October 7th. Finally, Vetr raised shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $122.43 price target for the company in a report on Tuesday, August 9th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. Monsanto has a consensus rating of “Hold” and a consensus price target of $114.06.

In other Monsanto news, EVP Steven Mizell sold 310 shares of the business’s stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $103.09, for a total value of $31,957.90. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Kerry J. Preete sold 2,745 shares of the business’s stock in a transaction that occurred on Thursday, November 17th. The shares were sold at an average price of $100.96, for a total value of $277,135.20. Following the completion of the sale, the executive vice president now owns 50,056 shares in the company, valued at approximately $5,053,653.76. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Related posts

Leave a Comment